These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22811881)

  • 1. Hepatoid adenocarcinoma of the peritoneal cavity: Prolonged survival after debulking surgery and 5-fluorouracil, leucovorin and oxaliplatin (FOLFOX) therapy.
    Lucas ZD; Shah M; Trivedi A; Dailey ME
    J Gastrointest Oncol; 2012 Jun; 3(2):139-42. PubMed ID: 22811881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoid malignancy of unknown origin--a diagnostic conundrum: review of literature and case report of collision with adenocarcinoma.
    Gopaldas R; Kunasani R; Plymyer MR; Bloch RS
    Surg Oncol; 2005 Jul; 14(1):11-25. PubMed ID: 15777886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma: a case report.
    Lin CW; Hsu CC; Chang HC; Sun YC; Sun PL; Hsu CY; Perng DS
    Cases J; 2009 Aug; 2():6317. PubMed ID: 19918575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma.
    Lyu N; Kong Y; Mu L; Lin Y; Li J; Liu Y; Zhang Z; Zheng L; Deng H; Li S; Xie Q; Guo R; Shi M; Xu L; Cai X; Wu P; Zhao M
    J Hepatol; 2018 Jul; 69(1):60-69. PubMed ID: 29471013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoid adenocarcinoma: a new clinicopathological entity and the hypotheses on carcinogenesis.
    Kishimoto T; Nagai Y; Kato K; Ozaki D; Ishikura H
    Med Electron Microsc; 2000; 33(2):57-63. PubMed ID: 11810459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.
    Schmoll HJ; Twelves C; Sun W; O'Connell MJ; Cartwright T; McKenna E; Saif M; Lee S; Yothers G; Haller D
    Lancet Oncol; 2014 Dec; 15(13):1481-1492. PubMed ID: 25456367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-fetoprotein-producing gastric carcinoma: A case report of a rare subtype and literature review.
    Sun N; Sun Q; Liu Q; Zhang T; Zhu Q; Wang W; Cao M; Zang QI
    Oncol Lett; 2016 May; 11(5):3101-3104. PubMed ID: 27123071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatoid adenocarcinoma of the colon: what should we target?
    Cappetta A; Bergamo F; Mescoli C; Lonardi S; Rugge M; Zagonel V
    Pathol Oncol Res; 2012 Jan; 18(1):93-6. PubMed ID: 21667305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
    Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
    Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
    Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
    Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alpha-fetoprotein-producing hepatoid adenocarcinoma of the endometrium.
    Adams SF; Yamada SD; Montag A; Rotmensch JR
    Gynecol Oncol; 2001 Nov; 83(2):418-21. PubMed ID: 11606109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoid adenocarcinoma of the renal pelvis producing alpha-fetoprotein of hepatic type and bile pigment.
    Ishikura H; Ishiguro T; Enatsu C; Fujii H; Kakuta Y; Kanda M; Yoshiki T
    Cancer; 1991 Jun; 67(12):3051-6. PubMed ID: 1710536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin reintroduction in patients previously treated with leucovorin, fluorouracil and oxaliplatin for metastatic colorectal cancer.
    Maindrault-Goebel F; Tournigand C; André T; Carola E; Mabro M; Artru P; Louvet C; de Gramont A
    Ann Oncol; 2004 Aug; 15(8):1210-4. PubMed ID: 15277260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary colon adenocarcinoma with choriocarcinoma differentiation: a case report and review of the literature.
    Boyce J; Tawagi K; Cole JT
    J Med Case Rep; 2020 Nov; 14(1):220. PubMed ID: 33190644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Oncology Multidisciplinary Research Group (GERCOR).
    Maindrault-Goebel F; de Gramont A; Louvet C; André T; Carola E; Gilles V; Lotz JP; Tournigand C; Mabro M; Molitor JL; Artru P; Izrael V; Krulik M
    Ann Oncol; 2000 Nov; 11(11):1477-83. PubMed ID: 11142489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoid adenocarcinoma of the stomach - a different histology for not so different gastric adenocarcinoma: a case report.
    Gálvez-Muñoz E; Gallego-Plazas J; Gonzalez-Orozco V; Menarguez-Pina F; Ruiz-Maciá JA; Morcillo MA
    Int Semin Surg Oncol; 2009 Aug; 6():13. PubMed ID: 19674468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer.
    Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Chun HK; Lee WY; Park YS
    Med Oncol; 2010 Dec; 27(4):1277-85. PubMed ID: 19949897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to chemotherapy in metastatic colorectal cancer after exposure to oxaliplatin in the adjuvant setting.
    Moreau LC; Rajan R; Thirlwell MP; Alcindor T
    Anticancer Res; 2013 Apr; 33(4):1765-8. PubMed ID: 23564831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial.
    Conroy T; Galais MP; Raoul JL; Bouché O; Gourgou-Bourgade S; Douillard JY; Etienne PL; Boige V; Martel-Lafay I; Michel P; Llacer-Moscardo C; François E; Créhange G; Abdelghani MB; Juzyna B; Bedenne L; Adenis A;
    Lancet Oncol; 2014 Mar; 15(3):305-14. PubMed ID: 24556041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6).
    Rovers KP; Bakkers C; Simkens GAAM; Burger JWA; Nienhuijs SW; Creemers GM; Thijs AMJ; Brandt-Kerkhof ARM; Madsen EVE; Ayez N; de Boer NL; van Meerten E; Tuynman JB; Kusters M; Sluiter NR; Verheul HMW; van der Vliet HJ; Wiezer MJ; Boerma D; Wassenaar ECE; Los M; Hunting CB; Aalbers AGJ; Kok NFM; Kuhlmann KFD; Boot H; Chalabi M; Kruijff S; Been LB; van Ginkel RJ; de Groot DJA; Fehrmann RSN; de Wilt JHW; Bremers AJA; de Reuver PR; Radema SA; Herbschleb KH; van Grevenstein WMU; Witkamp AJ; Koopman M; Haj Mohammad N; van Duyn EB; Mastboom WJB; Mekenkamp LJM; Nederend J; Lahaye MJ; Snaebjornsson P; Verhoef C; van Laarhoven HWM; Zwinderman AH; Bouma JM; Kranenburg O; van 't Erve I; Fijneman RJA; Dijkgraaf MGW; Hemmer PHJ; Punt CJA; Tanis PJ; de Hingh IHJT; ;
    BMC Cancer; 2019 Apr; 19(1):390. PubMed ID: 31023318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.